Compare Bio Protocol (BIO) vs Ethereum (ETH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Ethereum — how do they compare? Bio Protocol trades at Rp438.37 (market cap Rp995,56M, Rp174,03M 24h volume), while Ethereum trades at Rp33,394,112 (market cap Rp4.048,8T, Rp122,18T 24h volume). The key difference: Ethereum is far larger — about 4066856.8× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Ethereum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Ethereum for 104 Days on average.
| BIO | ETH | |
|---|---|---|
Market Cap | Rp995,56M | Rp4.048,8T |
Volume (24h) | Rp174,03M | Rp122,18T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 120,7M ETH |
Typical Hold Time | 17 Days | 104 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Ethereum is currently trading at Rp33,580,080 with a market cap of Rp4,068.14T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The asset is trading below its pivot point of Rp33,800,126, with key support at Rp33,243,942. Recent news highlights Ethereum's ecosystem growth potential and institutional interest in tokenization, though technical indicators suggest short-term caution.
Overall outlook remains cautiously optimistic for long-term holders given Ethereum's dominant position in DeFi and ongoing ecosystem development. Key opportunities include network upgrades and institutional adoption, while major risks include regulatory uncertainty and high volatility. The neutral RSI readings suggest potential for consolidation before next directional move.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Ethereum
A crypto asset designed for decentralized applications and deployment of smart contracts, which are created and operated without any fraud, interruption, control or interference from a third party. It is the second most valuable crypto asset after BTC.
Read more on ETH →
